|
RCC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
9.31189999997528E-07 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
8.159800E-03 |
| Stage1-vs-Stage3 |
9.837400E-01 |
| Stage1-vs-Stage4 |
2.608200E-01 |
| Stage2-vs-Stage3 |
2.630200E-02 |
| Stage2-vs-Stage4 |
4.076300E-03 |
| Stage3-vs-Stage4 |
3.178000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.63690000337868E-08 |
| Normal-vs-Asian |
4.44089209850063E-16 |
| Caucasian-vs-AfricanAmerican |
6.818400E-01 |
| Caucasian-vs-Asian |
1.440160E-01 |
| AfricanAmerican-vs-Asian |
1.960630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.115200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(81-100Yrs) |
8.66849999558994E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.654800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.682300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.099000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.049000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.121000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.376000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.503200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
6.424600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.7716000000334E-07 |
| Tall-VS-Other |
4.894800E-01 |
| Tall-VS-Normal |
3.01536573488193E-13 |
| Follicular-VS-Other |
2.264400E-02 |
| Follicular-VS-Normal |
2.43399999999561E-05 |
| Other-VS-Normal |
1.81279999900141E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.677700E-02 |
|
|
